A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS

Clinical trial NCT00625547 · COMPLETED

Trial details

NCT number: NCT00625547
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2003-01-01
Enrollment: 361

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.